SuperworthCaribou Biosciences shares outstanding CRBU
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 101M
- On a year earlier
- +8.6%
- more shares
Caribou Biosciences had 101M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 8.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 94.5M | +4% |
| FY2024 | 91.2M | +3% |
| FY2023 | 88.4M | +45% |
| FY2022 | 61M | +1% |
| FY2021 | 60.2M | +586% |
| FY2020 | 8.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 101M | +9% | |
| Q1 FY26 | 95.9M | +3% | |
| Q4 FY25 | 94.5M | +4% | |
| Q3 FY25 | 93.3M | +3% | |
| Q2 FY25 | 93M | +3% | |
| Q1 FY25 | 92.7M | +4% | |
| Q4 FY24 | 91.2M | +3% | |
| Q3 FY24 | 90.5M | +8% | |
| Q2 FY24 | 90.3M | +47% | |
| Q1 FY24 | 89.3M | +46% | |
| Q4 FY23 | 88.4M | +45% | |
| Q3 FY23 | 83.8M | +38% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Caribou Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.